ArticleThe Journal of infectious diseases2026
Antibodies to Tick Salivary Antigens AV422 and Calreticulin in Patients With Spotted Fever Group Rickettsioses and Other Febrile Illnesses in Northern Tanzania.
Article in The Journal of infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- One Health tick bite exposure biomarkers against Ixodes ricinus salivary peptides.Research square · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundTimely and accurate diagnosis of spotted fever rickettsioses (SFR) is difficult due to nonspecific symptoms and testing challenges. We evaluated serum antibodies to the tick salivary proteins AV422 and calreticulin as potential markers of recent tick exposure in febrile patients from northern Tanzania.
methodsWe recruited febrile patients at 2 hospitals in Moshi, Tanzania, from February 2012 through May 2014. Acute and convalescent sera from enrolled participants were tested against Rickettsia africae antigen using indirect immunofluorescence assays (IFAs). Participants with ≥4-fold rise in R africae IFA immunoglobulin G reciprocal titer between sera were classified as cases (n = 70), those with paired sera with reciprocal titer ≥64 but no ≥4-fold rise as exposed (n = 40), and participants with reciprocal titer <32 in either sera as unexposed (n = 38). Acute and convalescent sera were tested for calreticulin and AV422 antibodies using enzyme-linked immunosorbent assay.
resultsWe found significantly higher calreticulin antibody levels in acute sera of cases compared to exposed, unexposed, and the combined comparator of exposed and unexposed (adjusted mean difference [95% confidence interval {CI}], 17.49 [6.37-28.61]; 17.61 [6.55-28.67]; and 18.11 [9.13-27.10], respectively). Calreticulin distinguished cases from exposed and unexposed among persons 0-15 years old with positive predictive value of 0.77 (95% CI, .61-.88) and sensitivity of 0.94 (95% CI, .81-.99).
conclusionsIn the acute phase of febrile illness, measurement of calreticulin antibody, a proposed marker for tick exposure, was higher in patients with confirmed tick-borne illness and had reasonable diagnostic test characteristics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.